Human Disease Models

About Systasy Bioscience

Systasy Bioscience is a private German biotech firm that has developed a proprietary, breakthrough DNA barcoding technology for single-cell transcriptomics. Its platform enables highly multiplexed analysis of hundreds of pathological processes simultaneously, aiming to de-risk drug discovery by connecting compound activity to patient-specific data. The company operates as a technology provider and service partner for pharmaceutical companies, focusing on applications in pathway-based drug discovery, human disease models, and viral vector development for gene therapy. Key collaborations with entities like Ono Pharmaceutical and Evogene validate its platform's potential.

Other Broad (multiple disease areas) Drugs